Clinical Research Directory
Browse clinical research sites, groups, and studies.
Prognostic Value of BNP in MCS - a 25 Year Follow up Study
Sponsor: Rigshospitalet, Denmark
Summary
A biobank has been created to investigate the prognostic value of biomarkers (mainly BNP) in patients implanted with durable mechanical assist devices comparing patients with advanced HF supported by MCS with those who are transplanted and those who remain on optimal medical therapy. Patients will be followed up for 25 years after inclusion.
Official title: The Prognostic Value of proBNP in Patients Supported With Durable Mechanical Circulatory Assist Devices - a 25 Year Follow up Study.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
1000
Start Date
2020-09-18
Completion Date
2045-08-01
Last Updated
2021-05-05
Healthy Volunteers
Not specified
Interventions
Observation. No intervention per se.
Observation. No intervention (no collection of blood).
2) Observation and collection and of blood sample
All patients evaluated for adv HF (HTX/LVAD) will be offered to contribute to this database; Blood samples will be collected from all at baseline. Patients receiving LVAD will contribute on a yearly basis (or until withdrawal of consent). For other patients no further blood will be collected unless they receive an LVAD at a later point.
Locations (1)
Rigshospitalet
Copenhagen, DK, Denmark